log-rank test graphpad prism version 5.0b (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
log-rank test graphpad prism version 5.0b
Log Rank Test Graphpad Prism Version 5.0b, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-rank+test+graphpad+prism+version+5%2E0b/log+rank+test+graphpad+prism+version+5+0b/pm21354447-71-18-20
Average 90 stars, based on 1 article reviews
Log Rank Test Graphpad Prism Version 5.0b, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-rank+test+graphpad+prism+version+5%2E0b/log+rank+test+graphpad+prism+version+5+0b/pm21354447-71-18-20
Average 90 stars, based on 1 article reviews
log-rank test graphpad prism version 5.0b - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Validation of the "Metroticket" predictor in a cohort of patients transplanted for predominantly HBV-related hepatocellular carcinoma. Article Snippet: Background & Aims: The ‘‘Metroticket’’ prognostic model for Introduction survival post liver transplant for hepatocellular carcinoma (HCC) was developed from a European cohort of patients with predominantly alcoholic liver disease and hepatitis C-related HCC.. The aim of this study was to evaluate the prognostic value of the Metroticket in an independent cohort of patients with predominantly HBV-related HCC, in an Asia–Pacific transplant programme.. Methods: All patients listed for HCC at the New Zealand Liver Transplant Unit (NZLTU) between January 1998 and November 2009 were included. |